跳至主要内容
临床试验/JPRN-UMIN000002441
JPRN-UMIN000002441已完成未知

Tacrolimus (graceptor (R)) for GVHD prophylaxis after allogeneic stem cell transplantation - Tacrolimus for GVHD prophylaxis

Jikei university school of medicine0 个研究点目标入组 10 人开始时间: 2009年10月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who have internal organs dysfunction

研究者

相似试验

已完成
2 期
Phase II study with tacrolimus to prevent GVHD for reduced-intensity peripheral blood stem cell transplantation from an HLA-identical related donorAcute leukemia, Chronic leukemia, Myelodysplastic syndrome, Malignant lymphoma, Adult T cell leukemia/lymphoma
JPRN-UMIN000001146agoya Blood and Marrow Transplantation Group26
已完成
3 期
Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD PreventionAcute Biphenotypic LeukemiaMyeloproliferative NeoplasmNon-Hodgkin LymphomaHodgkins DiseaseMultiple MyelomaAcute Myeloid LeukemiaChronic Lymphocytic LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic SyndromeChronic Myelogenous Leukemia
NCT01951885Case Comprehensive Cancer Center101
进行中(未招募)
不适用
Topische Anwendung von Tacrolimus (Protopic) bei verschiedenen Formen des kutanen Lupus erythe-matodes im Rahmen einer klinischen Untersuchung an mehreren nationalen Zentren - entfällt
EUCTR2004-005020-41-DEHeinrich Heine Universität Düsseldorf30
招募中
不适用
Management of the combination of tacrolimus with azoles: effect of tacrolimus formulation on drug-drug interaction magnitudeMycoses due to opportunistic pathogensfungal infection in patients with immune deficiencies who would otherwise not be infected10017528
NL-OMON54925niversitair Medisch Centrum Groningen24
已完成
不适用
Combination therapy of tacrolimus and intravenous cyclophosphamide for remission induction of lupus nephritislupus nephritis
JPRN-UMIN000004893Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University16
Tacrolimus (graceptor (R)) for GVHD prophylaxis... | 临床试验